'Orphan Drugs & Rare Diseases', London, UK
14 October 2013 - 14 October 2013
United Kingdom
A conference on 'Orphan Drugs & Rare Diseases'will be held from 14 to 15 October 2013 in London, UK.
Within the EU population, rare diseases affect fewer than 5 patients in every 10,000. Although companies were reluctant to develop orphan drugs for these diseases, recent years have seen huge growth in orphan drug development.
This conference will focus on the current landscape of rare disease drug development. It will bring together a range of participants from the pharmaceutical industry to discuss regulatory policies, new drug discoveries, partnerships in clinical trials and drug development.For further information, please visit:
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/orphan-drugs-rare-diseases(opens in new window)
Within the EU population, rare diseases affect fewer than 5 patients in every 10,000. Although companies were reluctant to develop orphan drugs for these diseases, recent years have seen huge growth in orphan drug development.
This conference will focus on the current landscape of rare disease drug development. It will bring together a range of participants from the pharmaceutical industry to discuss regulatory policies, new drug discoveries, partnerships in clinical trials and drug development.For further information, please visit:
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/orphan-drugs-rare-diseases(opens in new window)